Showing results (151-160 of 215) with videos related to
Sort By:
Pageof 22
Journal of the National Cancer Institute|November 5, 1999
Weighing the risks and benefits of tamoxifen treatment for preventing breast cancerM H Gail, J P Costantino, J Bryant, et al.Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|March 4, 2000
Perspectives on surrogate end points in the development of drugs that reduce the risk of cancerG J Kelloff, C C Sigman, K M Johnson, et al.Journal of Cellular Biochemistry. Supplement|January 1, 1995
Strategies for phase II cancer chemoprevention trials: cervix, endometrium, and ovaryG J Kelloff, C W Boone, J A Crowell, et al.Oncology (Williston Park, N.Y.)|October 1, 1996
Strategies for identification and clinical evaluation of promising chemopreventive agentsG J Kelloff, E T Hawk, J A Crowell, et al.European Journal of Cancer (Oxford, England : 1990)|June 5, 2004
Prostate intraepithelial neoplasia in Noble rats, a potential intermediate endpoint for chemoprevention studiesK T Christov, R C Moon, D D Lantvit, et al.Seminars in Oncology|April 1, 1997
Progress in clinical chemopreventionG J Kelloff, E T Hawk, J E Karp, et al.Nutrition and Cancer|January 1, 1997
Effects of theaflavins on N-nitrosomethylbenzylamine-induced esophageal tumorigenesisM A Morse, L A Kresty, V E Steele, et al.Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.)|January 8, 1998
Effect of tea extracts, polyphenols, and epigallocatechin gallate on azoxymethane-induced colon cancerJ H Weisburger, A Rivenson, C Aliaga, et al.European Urology|May 15, 1999
Chemoprevention of prostate cancer: concepts and strategiesG J Kelloff, R Lieberman, V E Steele, et al.Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|February 10, 1998
Aromatase inhibitors as potential cancer chemopreventivesG J Kelloff, R A Lubet, R Lieberman, et al.Pageof 22